Next Article in Journal
Biodegradable Polymers and Stem Cells for Bioprinting
Next Article in Special Issue
Red Light Activation of Ru(II) Polypyridyl Prodrugs via Triplet-Triplet Annihilation Upconversion: Feasibility in Air and through Meat
Previous Article in Journal
The Traditional Medicine and Modern Medicine from Natural Products
Previous Article in Special Issue
Cellular Uptake and Photo-Cytotoxicity of a Gadolinium(III)-DOTA-Naphthalimide Complex “Clicked” to a Lipidated Tat Peptide
Open AccessArticle

Photoactivatable Caged Prodrugs of VEGFR-2 Kinase Inhibitors

Institute of Pharmacy, University of Kiel, Gutenbergstr. 76, D-24118 Kiel, Germany
*
Author to whom correspondence should be addressed.
Academic Editor: Wiktor Szymański
Molecules 2016, 21(5), 570; https://doi.org/10.3390/molecules21050570
Received: 16 March 2016 / Revised: 20 April 2016 / Accepted: 21 April 2016 / Published: 29 April 2016
(This article belongs to the Special Issue Photoresponsive Drugs)
In this study, we report on the design, synthesis, photokinetic properties and in vitro evaluation of photoactivatable caged prodrugs for the receptor tyrosine kinase VEGFR-2. Highly potent VEGFR-2 inhibitors 1 and 3 were caged by introduction of a photoremovable protecting group (PPG) to yield the caged prodrugs 4 and 5. As expected, enzymatic and cellular proliferation assays showed dramatically diminished efficacy of caged prodrugs in vitro. Upon ultraviolet (UV) irradiation of the prodrugs original inhibitory activity was completely restored and even distinctly reinforced, as was the case for the prodrug 4. The presented results are a further evidence for caging technique being an interesting approach in the protein kinase field. It could enable spatial and temporal control for the inhibition of VEGFR-2. The described photoactivatable prodrugs might be highly useful as biological probes for studying the VEGFR-2 signal transduction. View Full-Text
Keywords: photoactivatable prodrugs; caging; receptor tyrosine kinase; kinase inhibitors; VEGFR-2; 3,4-diarylmaleimides; photoremovable protecting group (PPG) photoactivatable prodrugs; caging; receptor tyrosine kinase; kinase inhibitors; VEGFR-2; 3,4-diarylmaleimides; photoremovable protecting group (PPG)
Show Figures

Graphical abstract

MDPI and ACS Style

Pinchuk, B.; Horbert, R.; Döbber, A.; Kuhl, L.; Peifer, C. Photoactivatable Caged Prodrugs of VEGFR-2 Kinase Inhibitors. Molecules 2016, 21, 570.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop